Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 308
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
How Red Light Holland Is Bringing Psilocybin Truffles Mainstream
Interview With Carlos Tanner
Why Ayahuasca Is Miley Cyrus’ ‘Favorite’ Drug
Patent Combining Psychedelics with Cannabinoids Allowed by USPTO
Mind Cure Announces Closing of $23 Million Bought Deal Offering Including...
Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future...
Silo Pharma Announces Private Placement of Equity Definitive Agreement for $4.275...
Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results...
Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider...
NeonMind Submits Applications to Health Canada for Product Formulas to Support...
Load more